机译:使用奈玛特韦及其衍生物对抗SARS-CoV-2感染的进展和挑战
Cancer Institute Department of Orthopedics, The Affiliated Hospital of Qingdao University;
Qingdao Cancer Institute, Qingdao University;
Department of Pharmacy, The Fifth Affiliated Hospital, Sun Yat-sen UniversitySchool of Life Sciences, Tsinghua University;
Nirmatrelvir; Pharmacology; Pharmacokinetics; Toxicology; Derivatives; COVID-19;
机译:Rebound of COVID-19 infection in patients with chronic lymphocytic leukemia treated for SARS-CoV-2 with Nirmatrelvir/Ritonavir or Molnupiravir
机译:Successful treatment of persisting SARS-CoV-2 infection in an immunocompromised patient with repeated nirmatrelvir/ritonavir courses: a case report
机译:Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
机译:VAST Challenge 2018:Mini-Challenge 1 Award:Applied Visual Data Science
机译:Advances in Applied Agricultural and Experimental Economics =农业与实验经济学的实证研究进展
机译:新合成的ant吨衍生物(derivatives吨氧丙醇胺)的降压活性,毒性和分子对接研究
机译:严重烧伤患者感染难治性\ / / infections infections infections infections infections
机译:三参数可调谐Tilt-Integral-Derivative(TID)控制器